日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanisms

酪蛋白激酶1δ/ε抑制通过细胞内在机制和微环境机制抑制CLL细胞增殖。

Mikulova, Antonia; Plesingerova, Hana; Chorvatova, Michaela; Kebkova, Pavlina; Bartosikova, Jana; Prochazkova, Petra; Verner, Jan; Mulidran, Dominik; Cada, Stepan; Vondalova-Blanarova, Olga; Kolcakova, Nela; Loja, Tomas; Kurucova, Terezia; Hoferkova, Eva; Tichy, Boris; Kotaskova, Jana; Mraz, Marek; Kubala, Lukas; Janovska, Pavlina; Bryja, Vitezslav

Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin.

肌酸激酶 B 是 c-Myb 的下游效应因子,它通过调节 N-钙黏蛋白来控制骨肉瘤细胞的迁移。

Pokludová Jana, Lapčík Petr, Zambo Iva Staniczková, Kohoutek Jiří, Zapletalová Danica, Múdry Peter, Adámková Dagmar, Červinka Jakub, Loja Tomáš, Lexa Matej, Verner Jan, Šmarda Jan, Bouchal Pavel, Knopfová Lucia, Beneš Petr

FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.

FoxO1-GAB1 轴调节慢性淋巴细胞白血病中的归巢能力和持续性 AKT 活性

Seda Vaclav, Vojackova Eva, Ondrisova Laura, Kostalova Lenka, Sharma Sonali, Loja Tomas, Mladonicka Pavlasova Gabriela, Zicha Daniel, Kudlickova Peskova Marie, Krivanek Jan, Liskova Kvetoslava, Kren Leos, Benes Vladimir, Musilova Litzmanova Katerina, Borsky Marek, Oppelt Jan, Verner Jan, Pospisilova Sarka, Brychtova Yvona, Panovska Anna, Tan Zhi, Zhang Shuxing, Doubek Michael, Amruz Cerna Katerina, Mayer Jiri, Mraz Marek

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells

新型CHK1抑制剂MU380在TP53突变型慢性淋巴细胞白血病细胞中表现出显著的单药活性。

Boudny, Miroslav; Zemanova, Jana; Khirsariya, Prashant; Borsky, Marek; Verner, Jan; Cerna, Jana; Oltova, Alexandra; Seda, Vaclav; Mraz, Marek; Jaros, Josef; Jaskova, Zuzana; Spunarova, Michaela; Brychtova, Yvona; Soucek, Karel; Drapela, Stanislav; Kasparkova, Marie; Mayer, Jiri; Paruch, Kamil; Trbusek, Martin